FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kaname Yoshizawa

Research Profile

Geographic Areas

Japan

Living Beings

Hepacivirus

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Case Control Studies

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Co-author Network

Publications

TOP 3
Susumu Morita; Satoru Joshita; Astushi Kamijo; Yoshihiko Katsuyama; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura; Nobuyoshi Yamamura; Kaname Yoshizawa; Masao Ota
Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis.
Akihiro Matsumoto; Susumu Morita; Eiji Tanaka; Takeji Umemura; Kaname Yoshizawa; Satoru Joshita
Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.
Kaname Yoshizawa; Masao Ota; Eiji Tanaka; Naoki Tanaka; Takeji Umemura; Masanori Abe; Tetsuya Ichijo; Satoru Joshita; Yoshihiko Katsuyama; Kendo Kiyosawa; Michiharu Komatsu; Akihiro Matsumoto; Morikazu Onji
Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kaname Yoshizawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susumu Morita; Satoru Joshita; Astushi Kamijo; Yoshihiko Katsuyama; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura; Nobuyoshi Yamamura; Kaname Yoshizawa; Masao Ota
Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis.
Human immunology 2013;74(2):219-22.
2012: Akihiro Matsumoto; Susumu Morita; Eiji Tanaka; Takeji Umemura; Kaname Yoshizawa; Satoru Joshita
Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.
Journal of gastroenterology 2012;47(9):1006-13.
2012: Kaname Yoshizawa; Masao Ota; Eiji Tanaka; Naoki Tanaka; Takeji Umemura; Masanori Abe; Tetsuya Ichijo; Satoru Joshita; Yoshihiko Katsuyama; Kendo Kiyosawa; Michiharu Komatsu; Akihiro Matsumoto; Morikazu Onji
Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.
Hepatology (Baltimore, Md.) 2012;56(2):668-76.
2012: Satoru Joshita; Atsushi Kamijo; Nozomi Kamijo; Yoshihiko Katsuyama; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Susumu Morita; Masao Ota; Tetsuya Ichijo; Yuki Ichikawa; Takeji Umemura; Kaname Yoshizawa; Eiji Tanaka
Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection.
Human immunology 2012;73(3):298-300.
2012: Takeji Umemura; Kaname Yoshizawa; Tetsuya Ichijo; Satoru Joshita; Yoshihiko Katsuyama; Masao Ota; Eiji Tanaka
Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2012;55(2):506-11.
2011: Yuki Ichikawa-Yamada; Satoru Joshita; Atsushi Kamijo; Takefumi Kimura; Akihiro Matsumoto; Susumu Morita; Yoshinori Tsukahara; Takeji Umemura; Kaname Yoshizawa; Tetsuya Ichijo; Eiji Tanaka
Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2011;41(9):904-9.
2011: Suguru Yoneda; Takeji Umemura; Satoru Joshita; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Yoshihiko Katsuyama; Masao Ota; Eiji Tanaka
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Hepatology research : the official journal of the Japan Society of Hepatology 2011;41(6):587-93.
2011: Suguru Yoneda; Takeji Umemura; Yoshihiko Katsuyama; Atsushi Kamijo; Satoru Joshita; Michiharu Komatsu; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.
The Journal of infectious diseases 2011;203(8):1087-95.
2011: Atsushi Kamijo; Kaname Yoshizawa; Satoru Joshita; Suguru Yoneda; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients.
Hepatology research : the official journal of the Japan Society of Hepatology 2011;41(4):350-7.
2011: Masao Ota; Takeji Umemura; Kaname Yoshizawa; Hideaki Hamano; Tetsuya Ito; Yoshihiko Katsuyama; Shigeyuki Kawa
Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population.
Disease markers 2011;31(4):223-9.
2011: Takeji Umemura; Suguru Yoneda; Kaname Yoshizawa; Tetsuya Ichijo; Satoru Joshita; Yoshihiko Katsuyama; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
Antiviral therapy 2011;16(7):1073-80.
2011: Yuichi Nozawa; Yukiko Sugiyama; Takeji Umemura; Kaname Yoshizawa; Mana Fukushima; Tetsuya Ichijo; Yuki Ichikawa; Satoru Joshita; Atsushi Kamijo; Takefumi Kimura; Akihiro Matsumoto; Susumu Morita; Eiji Tanaka
A case of pyogenic liver abscess infected with Fusobacterium necrophorum depicted by microscopy and confirmed by tissue culture.
Internal medicine (Tokyo, Japan) 2011;50(17):1815-9.
2011: Kaname Yoshizawa; Takeji Umemura; Masao Ota
Genetic background of autoimmune hepatitis in Japan.
Journal of gastroenterology 2011;46 Suppl 1():42-7.
2011: Takeji Umemura; Yoh Zen; Hideaki Hamano; Satoru Joshita; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa; Masao Ota; Shigeyuki Kawa; Yasuni Nakanuma; Eiji Tanaka
Clinical significance of immunoglobulin G4-associated autoimmune hepatitis.
Journal of gastroenterology 2011;46 Suppl 1():48-55.
2010: Tadanobu Nagaya; Naoki Tanaka; Takefumi Suzuki; Kenji Sano; Akira Horiuchi; Michiharu Komatsu; Takero Nakajima; Tomoko Nishizawa; Satoru Joshita; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Jun Nakayama; Eiji Tanaka; Toshifumi Aoyama
Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
Journal of hepatology 2010;53(4):724-31.
2010: Satoru Joshita; Takeji Umemura; Kaname Yoshizawa; Yoshihiko Katsuyama; Eiji Tanaka; Minoru Nakamura; Hiromi Ishibashi; Masao Ota
Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
Journal of hepatology 2010;53(3):537-41.
2010: Goro Tsuruta; Naoki Tanaka; Minoru Hongo; Michiharu Komatsu; Akira Horiuchi; Kaeko Hamamoto; Chieko Iguchi; Yoshiko Nakayama; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Eiji Tanaka
Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits.
Journal of gastroenterology 2010;45(6):666-72.
2010: Satoru Joshita; Takeji Umemura; Kaname Yoshizawa; Yoshihiko Katsuyama; Eiji Tanaka; Masao Ota
A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients.
Human immunology 2010;71(5):520-4.
2010: Satoru Joshita; Kaname Yoshizawa; Kenji Sano; Satoshi Kobayashi; Tomohiro Sekiguchi; Susumu Morita; Atsushi Kamijo; Michiharu Komatsu; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Eiji Tanaka
A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome.
Internal medicine (Tokyo, Japan) 2010;49(11):991-4.
2009: Satoru Joshita; Tetsuya Ichijo; Fumitaka Suzuki; Takahide Yokoyama; Yukiko Sugiyama; Mana Fukushima; Atsushi Kamijo; Michiharu Komatsu; Takeji Umemura; Kaname Yoshizawa; Shinichi Miyagawa; Eiji Tanaka
A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid.
Hepatology research : the official journal of the Japan Society of Hepatology 2009;39(2):207-12.
2009: Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Takahide Yokoyama; Shinji Okaniwa; Tadanobu Nagaya; Kaname Yoshizawa; Kendo Kiyosawa; Toshifumi Aoyama; Eiji Tanaka
Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.
Journal of gastroenterology 2009;44(6):577-82.
2009: Takeji Umemura; Tetsuya Ichijo; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Epidemiology of hepatocellular carcinoma in Japan.
Journal of gastroenterology 2009;44 Suppl 19():102-7.
2008: Haruaki Shirakawa; Akihiro Matsumoto; Satoru Joshita; Michiharu Komatsu; Naoki Tanaka; Takeji Umemura; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa; Eiji Tanaka
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
Hepatology (Baltimore, Md.) 2008;48(6):1753-60.
2008: Naoki Tanaka; Tadanobu Nagaya; Michiharu Komatsu; Akira Horiuchi; Goro Tsuruta; Haruaki Shirakawa; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Kendo Kiyosawa; Eiji Tanaka
Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(8):1104-11.
2008: Takeji Umemura; Masao Ota; Kaname Yoshizawa; Yoshihiko Katsuyama; Tetsuya Ichijo; Eiji Tanaka; Kendo Kiyosawa
Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese.
Hepatology research : the official journal of the Japan Society of Hepatology 2008;38(7):689-95.
2008: Kaname Yoshizawa; Haruaki Shirakawa; Tetsuya Ichijo; Takeji Umemura; Eiji Tanaka; Kendo Kiyosawa; Eri Imagawa; Kazuyuki Matsuda; Eiko Hidaka; Kenji Sano; Yuichi Nakazawa; Toshihiko Ikegami; Yasuhiko Hashikura; Shinichi Miyagawa; Masao Ota; Masayuki Nakano
De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis.
Clinical transplantation 2008;22(3):385-90.
2008: Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; Noboru Maki
Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
Intervirology 2008;51 Suppl 1():3-6.
2008: Shigeyuki Kawa; Kei Kitahara; Hideaki Hamano; Yayoi Ozaki; Norikazu Arakura; Kaname Yoshizawa; Takeji Umemura; Masao Ota; Sadaaki Mizoguchi; Yasunori Shimozuru; Seiamak Bahram
A novel immunoglobulin-immunoglobulin interaction in autoimmunity.
PloS one 2008;3(2):e1637.
2007: Takeji Umemura; Masao Ota; Kaname Yoshizawa; Yoshihiko Katsuyama; Tetsuya Ichijo; Eiji Tanaka; Shigeyuki Kawa; Kendo Kiyosawa
Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis.
Clinical immunology (Orlando, Fla.) 2007;122(3):338-42.
2007: Shuichi Yokosawa; Kaname Yoshizawa; Masao Ota; Yoshihiko Katsuyama; Shigeyuki Kawa; Tetsuya Ichijo; Takeji Umemura; Eiji Tanaka; Kendo Kiyosawa
A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1.
Hepatology (Baltimore, Md.) 2007;45(2):384-90.
2007: Takeji Umemura; Hidetomo Muto; Eiji Tanaka; Akihiro Matsumoto; Tetsuya Ichijo; Kaname Yoshizawa; T Akamatsu; Kendo Kiyosawa
Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.
Journal of viral hepatitis 2007;14(1):48-54.
2007: Masao Ota; Yoshihiko Katsuyama; Hideaki Hamano; Takeji Umemura; Akinori Kimura; Kaname Yoshizawa; Kendo Kiyosawa; Hirofumi Fukushima; Seiamak Bahram; Hidetoshi Inoko; Shigeyuki Kawa
Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis.
Immunogenetics 2007;59(1):45-52.
2006: Naoki Tanaka; Eiji Tanaka; Yo Sheena; Michiharu Komatsu; Wataru Okiyama; Noriko Misawa; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Akira Horiuchi; Kendo Kiyosawa
Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(8):956-63.
2006: Akinori Rokuhara; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura; Kaname Yoshizawa; Tatsuji Kimura; Noboru Maki; Kendo Kiyosawa
Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy.
Journal of gastroenterology 2006;41(8):785-90.
2006: Naoki Tanaka; Tetsuya Ichijo; Wataru Okiyama; Hidetomo Mutou; Noriko Misawa; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Laparoscopic findings in patients with nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(1):32-8.
2006: Kentaro Okubo; Kaname Yoshizawa; Wataru Okiyama; Kayoko Kontani; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiko Matsumoto; Eiji Tanaka; Kazuhiko Hora; Shigetaka Shimodaira; Kendo Kiyosawa
Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis.
Internal medicine (Tokyo, Japan) 2006;45(3):155-8.
2006: Takashi Muraki; Hideaki Hamano; Yasuhide Ochi; Kenichi Komatsu; Yuichi Komiyama; Norikazu Arakura; Kaname Yoshizawa; Masao Ota; Shigeyuki Kawa; Kendo Kiyosawa
Autoimmune pancreatitis and complement activation system.
Pancreas 2006;32(1):16-21.
2006: Noriko Misawa; Akihiro Matsumoto; Eiji Tanaka; Akinori Rokuhara; Kaname Yoshizawa; Takeji Umemura; Noboru Maki; Tatsuji Kimura; Kendo Kiyosawa
Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics.
Journal of medical virology 2006;78(1):68-73.
2005: Amal Gad; Eiji Tanaka; Akihiro Matsumoto; Moushira Abd-el Wahab; Abdelhamid Serwah; Fawzy Attia; Khalil Ali; Howayda Hassouba; Abd el-Raoof el-Deeb; Tetsuya Ichijyo; Takeji Umemura; Hidetomo Muto; Kaname Yoshizawa; Kendo Kiyosawa
Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(42):6607-12.
2005: Shigeyuki Kawa; Kaname Yoshizawa; Toshio Nikaido; Kendo Kiyosawa
Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.
The Journal of steroid biochemistry and molecular biology 2005;97(1-2):173-7.
2005: Eiji Tanaka; Akihiro Matsumoto; N Takeda; T-C Li; Takeji Umemura; Kaname Yoshizawa; Y Miyakawa; T Miyamura; Kendo Kiyosawa
Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan.
Journal of viral hepatitis 2005;12(4):439-42.
2005: Kenichi Komatsu; Hideaki Hamano; Yasuhide Ochi; Mari Takayama; Takashi Muraki; Kaname Yoshizawa; Akihiro Sakurai; Masao Ota; Shigeyuki Kawa
High prevalence of hypothyroidism in patients with autoimmune pancreatitis.
Digestive diseases and sciences 2005;50(6):1052-7.
2005: XiaoHong Sun; Akinori Rokuhara; Eiji Tanaka; Amal Gad; Hidetomo Mutou; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
Nucleotide mutations associated with hepatitis B e antigen negativity.
Journal of medical virology 2005;76(2):170-5.
2005: Kaname Yoshizawa; Masao Ota; Yoshihiko Katsuyama; Tetsuya Ichijo; Akihiro Matsumoto; Eiji Tanaka; Kendo Kiyosawa
Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis.
Journal of hepatology 2005;42(4):578-84.
2004: Kendo Kiyosawa; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Amal Gad; Eiji Tanaka
Hepatocellular carcinoma: recent trends in Japan.
Gastroenterology 2004;127(5 Suppl 1):S17-26.
2004: Kaname Yoshizawa
[Early diagnosis of acute hepatitis C--detection of anti-HCV antibody and HCV-RNA].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 7(Pt 1):353-6.
2004: Hidetomo Muto; Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
Journal of gastroenterology 2004;39(7):674-80.
2004: Jun Umino; Eiji Tanaka; Tetsuya Ichijoh; Takashi Muraki; Koji Orii; Kaname Yoshizawa; Kendo Kiyosawa
Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green.
Internal medicine (Tokyo, Japan) 2004;43(4):283-8.
2003: Amal Gad; Eiji Tanaka; Akihiro Matsumoto; Abd el-Hamid Serwah; Khalil Ali; Fathy Makledy; Ahmed el-Gohary; Koji Orii; Akihiro Ijima; Akinori Rokuhara; Kaname Yoshizawa; Zohair Nooman; Kendo Kiyosawa
Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence.
Journal of medical virology 2003;70(4):594-9.
2003: Takahiro Yamaura; Eiji Tanaka; Akihiro Matsumoto; Akinori Rokuhara; Koji Orii; Kaname Yoshizawa; Yuzo Miyakawa; Kendo Kiyosawa
A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
Journal of medical virology 2003;70(4):545-52.
2003: Kaname Yoshizawa; Masao Ota; Satoshi Saito; A Maruyama; Takahiro Yamaura; Akinori Rokuhara; Koji Orii; Tetsuya Ichijo; Akihiro Matsumoto; Eiji Tanaka; Kendo Kiyosawa
Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.
Tissue antigens 2003;61(2):159-65.
2002: Takahiro Yamaura; Kaname Yoshizawa; Akinori Rokuhara; Yoshio Nishizawa; Akihiro Matsumoto; Akira Horiuchi; Kouichi Miyazawa; Kendo Kiyosawa
[A case of a 85-year-old female with autoimmune hepatitis].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2002;99(12):1498-502.
2002: Kaname Yoshizawa; Daniel P Cioca; Shigeyuki Kawa; Eiji Tanaka; Kendo Kiyosawa
Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Cancer 2002;95(10):2243-51.
2002: Shigeyuki Kawa; Masao Ota; Kaname Yoshizawa; Akira Horiuchi; Hideaki Hamano; Yasuhide Ochi; Kohzo Nakayama; Yuriko Tokutake; Yoshihiko Katsuyama; Satoshi Saito; Osamu Hasebe; Kendo Kiyosawa
HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population.
Gastroenterology 2002;122(5):1264-9.
2002: Takeji Umemura; Harvey Alter; Eiji Tanaka; Koji Orii; Anthony E T Yeo; James Shih; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
Hepatology (Baltimore, Md.) 2002;35(4):953-9.
2001: Takeji Umemura; Harvey Alter; Eiji Tanaka; Anthony E T Yeo; James Shih; Koji Orii; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa
Association between SEN virus infection and hepatitis C in Japan.
The Journal of infectious diseases 2001;184(10):1246-51.
2001: Amal Gad; Eiji Tanaka; Koji Orii; Akinori Rokuhara; Zohair Nooman; A H Serwah; M Shoair; Kaname Yoshizawa; Kendo Kiyosawa
Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect.
Journal of gastroenterology 2001;36(11):753-8.
2001: Eiji Tanaka; N Takeda; L Tian-Chen; Koji Orii; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; T Iijima; T Takayama; T Miyamura; Kendo Kiyosawa
Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay.
Journal of gastroenterology 2001;36(5):317-21.
2000: Y Nishizawa; Eiji Tanaka; Koji Orii; Akinori Rokuhara; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa
Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Journal of gastroenterology and hepatology 2000;15(11):1292-7.
2000: H Inada; Kaname Yoshizawa; Masao Ota; Yoshihiko Katsuyama; Tetsuya Ichijo; Takeji Umemura; Eiji Tanaka; Kendo Kiyosawa
T cell repertoire in the liver of patients with primary biliary cirrhosis.
Human immunology 2000;61(7):675-83.
2000: Koji Orii; Eiji Tanaka; Akinori Rokuhara; A Maruyama; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa
Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus.
Intervirology 2000;43(3):139-45.
1999: Kaname Yoshizawa; Masao Ota; Yoshihiko Katsuyama; Tetsuya Ichijo; H Inada; Takeji Umemura; Eiji Tanaka; Kendo Kiyosawa
T cell repertoire in the liver of patients with autoimmune hepatitis.
Human immunology 1999;60(9):806-15.
1998: Mariko Kobayashi; Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; H Imai; T Sodeyama; Kendo Kiyosawa
Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C.
Journal of gastroenterology 1998;33(4):508-11.
1998: Kaname Yoshizawa; M Ota; Kendo Kiyosawa
Cytotoxic T lymphocyte clone specific for autologous human hepatocellular carcinoma cell line SUHC-1.
Journal of gastroenterology and hepatology 1998;13(1):29-33.
1996: H Mori; K Yabu; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
Journal of gastroenterology and hepatology 1996;11(8):697-704.
1996: Shigeyuki Kawa; Kaname Yoshizawa; M Tokoo; H Imai; H Oguchi; Kendo Kiyosawa; T Homma; T Nikaido; K Furihata
Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.
Gastroenterology 1996;110(5):1605-13.
1994: Kendo Kiyosawa; Eiji Tanaka; T Sodeyama; Kaname Yoshizawa; K Yabu; K Furuta; H Imai; Y Nakano; S Usuda; K Uemura
Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group.
Gastroenterology 1994;106(6):1596-602.
1994: K Yabu; Kendo Kiyosawa; H Mori; A Matsumoto; Kaname Yoshizawa; Eiji Tanaka; S Furuta
Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C.
Scandinavian journal of gastroenterology 1994;29(5):474-9.
1994: K Yabu; Kendo Kiyosawa; S Ako; S Usuda; Kaname Yoshizawa; Eiji Tanaka; T Sodeyama; S Furuta
Type C chronic hepatitis associated with thrombocytopenia in two patients.
Journal of gastroenterology and hepatology 1994;9(1):99-104.
1993: Kaname Yoshizawa; Kendo Kiyosawa; S Yamada; K Furuta; K Yabu; Kiyoshi Kitano; Taiji Akamatsu; J Nakayama; Tsutomu Katsuyama; H Matsunami
Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient.
Cancer genetics and cytogenetics 1993;71(2):155-63.
1993: S Usuda; Kaname Yoshizawa; K Yabu; Kendo Kiyosawa
Immunological responses against an autologous human hepatocellular carcinoma cell line.
Journal of gastroenterology and hepatology 1993;8(6):517-23.
1993: T Seki; Kendo Kiyosawa; M Ota; S Furuta; H Fukushima; Eiji Tanaka; Kaname Yoshizawa; T Kumagai; Nobuhisa Mizuki; A Ando
Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients.
Hepatology (Baltimore, Md.) 1993;18(1):73-8.
1993: Y Nakano; Kendo Kiyosawa; T Sodeyama; Eiji Tanaka; Kaname Yoshizawa; K Furuta; Y Nakatsuji; A Urushihara; S Furuta
Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon.
Scandinavian journal of gastroenterology 1993;28(4):335-42.
1992: Kaname Yoshizawa; Kendo Kiyosawa; K Yabu; S Usuda; S Shimizu; Y Fujimori; Kenji Mukawa; Eiji Tanaka; T Sodeyama; S Furuta
Caroli's disease in three siblings.
Gastroenterologia Japonica 1992;27(6):780-4.
1992: Kaname Yoshizawa; Kendo Kiyosawa; S Usuda; K Yabu; Y Nakatsuji; S Yamada; K Furuta; Eiji Tanaka; T Sodeyama; S Furuta
New hepatocellular carcinoma cell line SUHC-1 established from a patient with hepatitis C virus RNA in serum.
Japanese journal of cancer research : Gann 1992;83(8):871-7.
1992: Eiji Tanaka; Kendo Kiyosawa; T Sodeyama; T Hayata; Y Ohike; Y Nakano; Kaname Yoshizawa; S Furuta; Y Watanabe; J Watanabe
Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors.
The American journal of tropical medicine and hygiene 1992;46(4):460-4.
1991: T Hayata; Y Nakano; Kaname Yoshizawa; T Sodeyama; Kendo Kiyosawa
Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C.
Hepatology (Baltimore, Md.) 1991;13(6):1022-8.
1991: Eiji Tanaka; Kendo Kiyosawa; T Sodeyama; Y Nakano; Kaname Yoshizawa; T Hayata; S Shimizu; Y Nakatsuji; Y Koike; S Furuta
Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis.
Journal of medical virology 1991;33(2):117-22.
1990: Kendo Kiyosawa; T Sodeyama; Eiji Tanaka; Y Gibo; Kaname Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; Robert Purcell
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
Hepatology (Baltimore, Md.) 1990;12(4 Pt 1):671-5.
1987: Kendo Kiyosawa; Y Gibo; T Sodeyama; K Furuta; H Imai; H Yoda; Y Koike; Kaname Yoshizawa; S Furuta
Possible infectious causes in 651 patients with acute viral hepatitis during a 10-year period (1976-1985).
Liver 1987;7(3):163-8.
1986: Kaname Yoshizawa; K Yabu; Y Imai; K Uemura; M Nakamura; H Yoda; Y Oike; S Wada; Eiji Tanaka; Y Gibo
[A case of HBV carrier with acute hepatitis type B developed after initial infection in adulthood].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 1986;83(9):2076-9.